- Home
- APD vs BSX Comparison
APD vs BSX Comparison
Compare APD & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APD | BSX |
|---|---|---|
| Founded | 1940 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.3B | 68.0B |
| IPO Year | 1994 | 2010 |
Fundamental Metrics
Financial Performance| Metric | APD | BSX |
|---|---|---|
| Price | $307.15 | $45.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 31 |
| Target Price | ★ $342.35 | $59.24 |
| AVG Volume (30 Days) | 858.2K | ★ 13.8M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ $12,037,300,000.00 | $9,076,000,000.00 |
| Revenue This Year | $5.99 | $5.41 |
| Revenue Next Year | $5.80 | $4.85 |
| P/E Ratio | ★ N/A | $29.53 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $229.11 | $41.39 |
| 52 Week High | $314.87 | $105.65 |
Technical Indicators
Market Signals| Indicator | APD | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 72.04 | 58.77 |
| Support Level | $289.62 | $42.31 |
| Resistance Level | $311.09 | $46.06 |
| Average True Range (ATR) | 4.87 | 1.13 |
| MACD | 3.26 | 0.45 |
| Stochastic Oscillator | 98.33 | 97.00 |
Price Performance
Historical ComparisonAbout APD Air Products and Chemicals Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the world's largest supplier of hydrogen and helium. It has a unique portfolio serving customers across industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated roughly $12 billion in revenue in fiscal 2025.
About BSX Boston Scientific Corporation
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.